NSE / BSEHealthcare
β‚Ή678.85+1.70+0.25%
P/E513.0Mkt Capβ‚Ή9.41 K CrEV/EBITDA49.9

HealthCare Global Enterprises Limited

P/E513.0Mkt Capβ‚Ή9.41 K CrEV/EBITDA49.9
Company Profile

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–² 19.76% over 1Y
Monthly Returns

Historically, Apr has averaged the highest return (+5.9%); Dec the lowest (-4.2%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-10.7%Negative MonthJan 2026: -10.67%-3.3%Negative MonthFeb 2026: -3.31%-8.3%Negative MonthMar 2026: -8.30%+9.1%Positive MonthApr 2026: +9.12%+11.2%Positive MonthMay 2026: +11.17%-0.8%Neutral MonthJun 2026: -0.83%+7.5%*Positive MonthJul 2026: +7.55%β€”β€”β€”β€”β€”
2025+4.6%Positive MonthJan 2025: +4.62%-1.7%Neutral MonthFeb 2025: -1.67%+6.9%Positive MonthMar 2025: +6.86%+4.6%Positive MonthApr 2025: +4.57%-3.6%Negative MonthMay 2025: -3.60%+2.1%Positive MonthJun 2025: +2.12%+12.2%Positive MonthJul 2025: +12.22%+8.2%Positive MonthAug 2025: +8.20%-3.8%Negative MonthSep 2025: -3.77%+15.7%Positive MonthOct 2025: +15.65%-2.9%Negative MonthNov 2025: -2.94%-8.8%Negative MonthDec 2025: -8.82%
2024+1.5%Neutral MonthJan 2024: +1.50%-2.4%Negative MonthFeb 2024: -2.37%-6.7%Negative MonthMar 2024: -6.66%+8.3%Positive MonthApr 2024: +8.28%-1.5%Neutral MonthMay 2024: -1.49%+5.3%Positive MonthJun 2024: +5.35%-6.8%Negative MonthJul 2024: -6.81%+9.0%Positive MonthAug 2024: +8.98%+8.4%Positive MonthSep 2024: +8.36%+7.4%Positive MonthOct 2024: +7.45%+11.9%Positive MonthNov 2024: +11.93%-2.7%Negative MonthDec 2024: -2.68%
2023-1.0%Neutral MonthJan 2023: -0.96%-1.6%Neutral MonthFeb 2023: -1.58%-6.3%Negative MonthMar 2023: -6.30%+2.2%Positive MonthApr 2023: +2.15%+17.4%Positive MonthMay 2023: +17.37%+1.2%Neutral MonthJun 2023: +1.17%+1.5%Neutral MonthJul 2023: +1.54%+8.1%Positive MonthAug 2023: +8.10%+2.3%Positive MonthSep 2023: +2.33%+3.6%Positive MonthOct 2023: +3.59%-0.1%Neutral MonthNov 2023: -0.12%-1.3%Neutral MonthDec 2023: -1.26%
2022+3.6%Positive MonthJan 2022: +3.60%-7.8%Negative MonthFeb 2022: -7.79%+18.2%Positive MonthMar 2022: +18.20%+5.2%Positive MonthApr 2022: +5.17%-0.8%Neutral MonthMay 2022: -0.85%-1.2%Neutral MonthJun 2022: -1.23%-3.1%Negative MonthJul 2022: -3.13%+1.5%Neutral MonthAug 2022: +1.50%+4.9%Positive MonthSep 2022: +4.94%+0.3%Neutral MonthOct 2022: +0.26%+2.8%Positive MonthNov 2022: +2.83%-2.8%Negative MonthDec 2022: -2.76%
2021β€”β€”β€”β€”β€”+19.7%Positive MonthJun 2021: +19.73%+13.5%Positive MonthJul 2021: +13.46%-5.4%Negative MonthAug 2021: -5.36%+2.7%Positive MonthSep 2021: +2.69%-8.9%Negative MonthOct 2021: -8.88%+12.7%Positive MonthNov 2021: +12.69%-5.6%Negative MonthDec 2021: -5.57%
AvgΒ±SD-0.4%Β±5.5%-3.3%Β±2.3%+0.8%Β±10.3%+5.9%Β±2.5%+4.5%Β±8.2%+4.4%Β±7.2%+4.1%Β±7.6%+4.3%Β±5.5%+2.9%Β±4.0%+3.6%Β±8.1%+4.9%Β±6.3%-4.2%Β±2.7%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.025x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή1.28 K Crβ–² 9.1%
EBITDA Growthβ€”
Net Profitβ‚Ή4.00 Crβ–Ό 87.9%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 576.5%
Revenue CAGR 5Y11.2%
EBITDA CAGR 5Y15.7%
Net Profit CAGR 5Y0.0%
NP Growth 1Y-87.9%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή1.28 K Crβ€”β‚Ή4.00 Crβ€”β€”0.3%9.1%-87.9%
Mar 2024β‚Ή1.17 K Crβ€”β‚Ή33.00 Crβ€”β€”2.8%16.4%-17.5%
Mar 2023β‚Ή1.01 K Crβ€”β‚Ή40.00 Crβ€”β€”3.5%18.4%5.3%
Mar 2022β‚Ή850.00 Crβ€”β‚Ή38.00 Crβ€”β€”3.5%39.6%-119.8%
Mar 2021β‚Ή609.00 Crβ€”β‚Ή-192.00β€”β€”-20.8%-11.5%262.3%
Mar 2020β‚Ή688.00 Crβ€”β‚Ή-53.00β€”β€”-8.6%7.5%-857.1%
Mar 2019β‚Ή640.00 Crβ€”β‚Ή7.00 Crβ€”β€”1.1%9.2%-72.0%
Mar 2018β‚Ή586.00 Crβ€”β‚Ή25.00 Crβ€”β€”3.9%7.5%31.6%
Mar 2017β‚Ή545.00 Crβ€”β‚Ή19.00 Crβ€”β€”3.5%15.7%-480.0%
Mar 2016β‚Ή471.00 Crβ€”β‚Ή-5.00β€”β€”-1.0%12.1%150.0%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales3494204715455866406886098501,0061,1711,2771,310
Total Expenses3363644074624985465735357038249701,0651,096
EBIT / Operating Profit13566483889411674147181201211213
OPM %4%13%14%15%15%15%17%12%17%18%17%17%16%
Other Income30-171913-19-12965704-8
Finance Costs28323416274883634341508489
Depreciation & Amortisation2833374444477987888997111115
Profit Before Tax-40-8-9293713-65-205815854200
Tax %-1%-69%-45%34%32%42%-19%-7%53%30%39%82%-
Net Profit / PAT-40-2-519257-53-1923840334-13
EPS (β‚Ή)-5.79-0.34-0.562.272.860.82-6.01-15.282.752.892.350.25-0.94
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
HealthCare Global Enterprises Limitedthis co.β‚Ή9.41 K Crβ‚Ή1.28 K Cr513.007.9549.869.1%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of HealthCare Global Enterprises Limited and the metrics that matter.

Browse the full Equiscale Academy